Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, some hunger usually remains on Wegovy — it is reduced, not eliminated. Semaglutide lowers appetite by acting on GLP-1 receptors in the brain and gut, slowing how quickly your stomach empties and signalling fullness sooner. Most people find they stop thinking about food as often, but hunger does not disappear entirely, and that is normal. These are prescription-only medicines; a prescriber assesses whether Wegovy is clinically suitable for you before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the first Monday after your initial Wegovy injection. You sit down to lunch and notice you are halfway through your plate and simply not interested in the rest. That is the GLP-1 effect working, gastric emptying slows, and satiety signals reach the brain earlier than they used to. For most people, this shift starts at the lower doses and becomes more pronounced as the dose increases over the following months.
That said, hunger does not vanish. Many people describe it as quieter rather than absent, a background murmur instead of the loud, insistent signal they were used to. Early in treatment, at the 0.25mg or 0.5mg stages, the change can feel subtle. This is by design: the titration schedule exists partly to let your body adapt, not to suppress appetite fully from day one. The full picture of how Wegovy works explains this dose-by-dose journey in more detail.
The practical upshot: if you are in your first four to eight weeks and still feeling hungry at the 0.5mg stage, that is expected and well within the normal range for this point in the titration. Give the process time, and keep notes on when hunger is strongest, that pattern matters later.
There are a few distinct kinds of hunger, and Wegovy addresses them differently. If you are curious about whether you should expect to feel hungry on Wegovy at all, the short answer is that physiological hunger, the stomach-growling kind driven by your body genuinely needing fuel, tends to be significantly blunted by semaglutide. The STEP 1 trial, published in the New England Journal of Medicine, reported an average body-weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose, which reflects real, sustained appetite change at a population level.
Emotional and habitual hunger are a different matter. The urge to eat because you are bored, stressed, tired, or simply because it is 8pm and the television is on does not have the same biological root. Semaglutide does not fully rewire those cues. Many people on Wegovy find that emotional eating patterns need separate, deliberate attention alongside the medicine.
There is also the question of timing. Hunger often returns more noticeably in the final day or two before your next weekly injection, as semaglutide levels in the blood naturally fall. This is not a sign the medicine has stopped working. It is pharmacokinetics. Noting which day of the week this happens and adjusting what you eat on those days can make a real difference.
The appetite reduction Wegovy creates is most useful when the food you do eat is doing real work. Because you are eating less overall, protein becomes more important, not less, it preserves muscle mass and keeps you fuller for longer. Eating well on Wegovy covers this in detail, but the short version is: lean protein, vegetables with fibre, and enough water.
Some people experience what feels like increased hunger shortly after eating, this can actually be a sign of low blood sugar following a fast gastric response, rather than true appetite. Eating more slowly, choosing lower-glycaemic-index foods, and avoiding very sugary snacks helps here. The NHS semaglutide guidance recommends pairing Wegovy with a reduced-calorie diet and increased activity for exactly this reason: the medicine changes the appetite signal, but your habits shape what you do with that signal.
If you are genuinely unsure whether the hunger you are feeling is normal at your current dose, that is worth raising with a prescriber. You should never try to self-manage by adjusting your dose or timing.
If hunger feels entirely unchanged after several weeks at your current dose (not just present, but no different from before you started) that is worth discussing. A few things could explain it. The injection technique might need checking (injecting into scar tissue or muscle rather than fat reduces absorption). A dose that has been stored incorrectly can lose potency. Or the dose may simply need reviewing by the prescriber, which is a routine part of ongoing treatment.
We hear this from patients fairly regularly: they assumed persistent hunger meant the medicine was not working for them personally, when a straightforward technique adjustment resolved it. If you are at a point where you feel still hungry on Wegovy despite doing everything right, do not quietly stop treatment without speaking to a clinician first.
Honest acknowledgement: if you are reading this because you are frustrated (you expected more of a change and it has not quite arrived) that is an understandable place to be. Most people do see a meaningful shift, but the timeline is not identical for everyone, and the medicine works best as part of a supported clinical plan rather than in isolation. If you want to talk through where you are in treatment, our prescribers are available seven days a week. Speak to our prescribers to start a free consultation or to review how things are going.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.